CDSI News and Events

News

Nov. 2, 2023

The Centers for Disease Control and Prevention distribute guidance to patients and providers based on research performed by CDSI principal investigators Dr. Cosby Stone, Jr. and Dr. Elizabeth Phillips. Their work, conducted in collaboration with an international team of researchers, informs care for patients labeled "penicillin-allergic.”

Read Dr. Stone's blog post on the CDC website here: "Antibiotic Stewardship when an Allergy Label is Present Improves Our Antibiotic Care and Treatment Outcomes"

Past Speakers

Center for Drug Safety and Immunology Seminar Series 2023
David Koelle, MD Creation and Validation of Large, Diverse Data Sets of Virus-reactive T Cell Receptors November 13, 2023
Ido Amit, PhD The power of ONE: Immunology in the age of single cell genomics March 20, 2023
Mary Carrington, PhD Effect of HLA-I Signal Peptide Variation on HLA-E Expression and NK Cell Function January 9, 2023

Seminar Series 2022

 

October 24, 2022

Mona Mashayekhi, MD, PhD

Instructor, physician-scientist, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Vanderbilt University Medical Center

The Effects of Anti-Diabetes on Inflammation in Obesity

---

September 26, 2022

David M. Patrick, MD, PhD

Assistant Professor of Medicine, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center

The Immunoproteasome: A Critical Mediator of Immune Activation in Arterial Hypertension

---

September 19, 2022

Nathaniel Bloodworth, MD, PhD

VUMC Harrison Society, Division of Clinical Pharmacology, Laboratory of David G. Harrison

Identifying Immunogenic Neoantigens in Hypertension

---

August 15, 2022

Margaret L. Axelrod, PhD

Recent PhD Graduate, Balko Laboratory 

Cytotoxic T cells Specific for Alpha-Myosin Drive Immunotherapy Related Myocarditis

---

April 25, 2022

Andrea Raye Shiakolas, PhD

Postdoctoral Fellow, Georgiev Laboratory, PMI

Antibody Discovery via LIBRA-seq: Linking B cell Receptor to Antigen Specificity Through Screening

---

April 11, 2022

Paul Norman, PhD

Associate Professor, Department of Immunology and Microbiology, University of Colorado School of Medicine

Co-evolution of Polymorphic Immune Genes Across Human Populations

---

March 21, 2022 

Jonathan A. Kropski, MD

Associate Professor of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center; Associate Professor of Cell and Developmental Biology

Epithelial Repair and Remodeling at Single-Cell Resolution

---

March 7, 2022

Jeffrey C. Rathmell, PhD

Cornelius Vanderbilt Chair in Immunobiology; Director, Vanderbilt Center for Immunology; Professor of Pathology, Microbiology and Immunology

Fueling T Cells and Immunometabolism in T cell-Mediated Inflammation

 

Past Events

Posters from the American Academy of Allergy, Asthma, and Immunology (AAAAI) Meeting  Phoenix, AZ   -   February 25 - 28, 2022
Grace Koo, MD A Two-Year Experience DelabelIng Low-Risk Penicillin Allergy in the Critical Care setting: Benefits OBSERVED for the Most Vulnerable
Jessica Plager, MD Already on the Treatment: A CASE of IgE-Mediated Insulin Hypersensitivity
Andrew Gibson, PhD   Single-cell multi-omic approaches define common molecular and cellular signals of dominant antigen-driven cells at the site of drug-induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) tissue damage.